Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma

被引:24
作者
Arvat, E
Giordano, R
Ramunni, J
Arnaldi, G
Colao, A
Deghenghi, R
Lombardi, G
Mantero, F
Camanni, F
Ghigo, E
机构
[1] Univ Turin, Div Endocrinol, Ancona, Italy
[2] Europeptides, Argenteuil, France
关键词
D O I
10.1210/jc.83.12.4207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We previously reported that in Cushing's disease (CD) the ACTH- and cortisol (F)-releasing activity of Hexarelin (HEX), a GH secretagogue, is exaggerated with respect to that in normal subjects and is higher than that of human CRH (hGRH), but it is absent in Cushing's syndrome. Our aim was to extend the study about the effects of HEX (2.0 mu g/kg, iv) on ACTH and F secretion in 21 patients with CD (3 men and 18 women, 16-68 yr old). Based on magnetic resonance imaging, 15 CD patients had pituitary microadenoma, and 6 had macroadenoma. The results in CD patients were compared with those in 27 normal age-matched controls (NS; 10 men and 17 women, 24-69 yr old). Basal ACTH and F levels in CD were similar in patients with microadenom (mean +/- SEM, 78.3 +/- 7.2 pg/mL, and 237.1 +/- 23.6 mu g/L, respectively) and macroadenoma (57.4 +/- 9.0 pg/mL and 196.4 +/- 20.1 mu g/L, respectively) and were higher (P < 0.001) than those in NS (11.7 +/- 2.0 pg/mL and 115.3 +/- 6.7 mu g/L, respectively). In microadenoma CD patients, HEX induced marked ACTH and F increases (Delta peak, mean +/- SEM: 261.2 +/- 77.6 pg/mL, and 226.1 +/- 87.2 mu g/L, respectively), which were higher (P < 0.04) than those induced by hCRH (45.6 +/- 16.9 pg/mL and 84.6 +/- 25.7 mu g/L, respectively). Moreover, in microadenoma CD patients, the ACTH and F responses to HEX were higher (P < 0.001) than those in NS (18.5 +/- 4.0 pg/mL and 36.1 +/- 6.8 mu g/L, respectively). In macroadenoma CD patients, HEX induced a slight, but significant increase (P < 0.02) in ACTH and F levels (33.9 +/- 18.0 pg/mL and 89.6 +/- 54.3 mu g/L, respectively), which was not significantly different from that elicited by hCRH (20.0 +/- 7.0 pg/mL and 54.8 +/- 21.3 mu g/L, respectively). In macroadenoma CD patients, the ACTH and F responses to HEX and hCRH were, in turn, similar to those in NS. In conclusion, our findings demonstrate that the ACTH and F hyperresponsiveness to HEX is present in Cushing's disease with micro-, but not macro- ACTH-secreting pituitary adenoma. This finding agrees with other evidence pointing toward differences in the hormonal behavior between micro- and ACTH-secreting pituitary macroadenomas.
引用
收藏
页码:4207 / 4211
页数:5
相关论文
共 35 条
  • [1] Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans
    Arvat, E
    Maccagno, B
    Ramunni, J
    DiVito, L
    Broglio, F
    Deghenghi, R
    Camanni, F
    Ghigo, E
    [J]. NEUROENDOCRINOLOGY, 1997, 66 (06) : 432 - 438
  • [2] Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH
    Arvat, E
    diVito, L
    Maccagno, B
    Broglio, F
    Boghen, MF
    Deghenghi, R
    Camanni, F
    Ghigo, E
    [J]. PEPTIDES, 1997, 18 (06) : 885 - 891
  • [3] Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans
    Arvat, E
    Maccagno, B
    Ramunni, J
    Di Vito, L
    Gianotti, L
    Broglio, F
    Benso, A
    Deghenghi, R
    Camanni, F
    Ghigo, E
    [J]. NEUROENDOCRINOLOGY, 1998, 67 (05) : 310 - 316
  • [4] BINDING OF A GROWTH-HORMONE RELEASING HEXAPEPTIDE TO SPECIFIC HYPOTHALAMIC AND PITUITARY BINDING-SITES
    CODD, EE
    SHU, AYL
    WALKER, RF
    [J]. NEUROPHARMACOLOGY, 1989, 28 (10) : 1139 - 1144
  • [5] Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess
    Colombo, P
    Passini, E
    Re, T
    Faglia, G
    Ambrosi, B
    [J]. CLINICAL ENDOCRINOLOGY, 1997, 46 (06) : 661 - 668
  • [6] Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression
    Cordido, F
    Peino, R
    Penalva, A
    Alvarez, CV
    Casanueva, FF
    Dieguez, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) : 914 - 918
  • [7] Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome
    Cuneo, RC
    Lee, W
    Harper, J
    Mitchell, K
    Ward, G
    Atkinson, RL
    Salkield, I
    Cameron, DP
    [J]. CLINICAL ENDOCRINOLOGY, 1997, 46 (05) : 607 - 618
  • [8] Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors
    de Keyzer, Y
    Lenne, F
    Bertagna, X
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 137 (06) : 715 - 718
  • [9] Deghenghi R, 1995, J PEDIATR ENDOCR MET, V8, P311
  • [10] Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6
    Dickson, SL
    Luckman, SM
    [J]. ENDOCRINOLOGY, 1997, 138 (02) : 771 - 777